Feature | May 15, 2012| Dave Fornell

Trends and Advances in Cardiac SPECT and SPECT/CT

Myocardial perfusion study performed on a Philips Precedence SPECT/CT system showing ischemia.

Single photon emission computed tomography (SPECT) remains a well-entrenched imaging modality for nuclear myocardial perfusion imaging (MPI) more than 30 years after its introduction. Due to SPECT’s reliability, cost-effectiveness and the wealth of data showing its clinical validation, it remains more common in MPI than its competition, positron emission tomography (PET). This is despite data showing PET’s much shorter scan times, fewer artifacts and better accuracy. 

The high cost of the only FDA-approved, generator-based PET MPI agent, CardioGen-82, is a key factor keeping SPECT as the dominant modality. Cardiac PET took a further blow this past year when CardioGen-82 was abruptly pulled off the U.S. market in July 2011, after two patients set off radiation detectors at U.S. border crossings due to strontium breakthroughs. The agent uses a strontium (Sr)-82 generator to produce a rubidium (Rb)-82 radiotracer injection, but it requires close daily monitoring to prevent breakthroughs. The manufacturer, Bracco, is working with the FDA to bring the radiotracer back to market.

While SPECT technology has remained somewhat stagnant over the years, recent advances have improved the speed of exams and the diagnostic accuracy of the modality. 

New gamma camera technology has allowed imaging times to be reduced from about 15-20 minutes down to about two to four minutes. Advances include both new camera design for better photon acquisition and sensitivity and better image reconstruction software.[1] 

Wide beam reconstruction (WBR), a software program from UltraSPECT, reduces both dose and image acquisition time by 50 percent for SPECT MPI.[2] Researchers found that with either half the dose of Tc-99m sestamibi or half the acquisition time, WBR resulted in image quality superior to processing with today’s widely used OSEM (ordered subset expectation maximization) software. WBR’s reconstruction algorithm incorporates depth-dependent resolution recovery and image noise modeling to deliver a higher quality image with lower count density data. 

Newer Systems

The adoption of combined SPECT/CT in one imaging system using a single patient table is growing. The combination of CT (computed tomography) offers anatomical imaging in addition to the functional molecular imaging of SPECT. In addition, CT is used for attenuation correction, resulting in better SPECT image quality and reduction in attenuation artifacts, especially in obese patients. 

A major trend is the development of new dedicated cameras/detectors for cardiac-specific imaging. Spectrum Dynamics D-SPECT last year introduced a new-generation cadmium zinc telluride (CZT) detector that enables high-resolution, low-dose nuclear scans.

Frost & Sullivan recently recognized Siemens with the 2011 North America Product Differentiation Excellence of the Year Award for its IQ-SPECT system. It offers high-quality imaging by achieving maximum counts in one-fourth the amount of time required by conventional SPECT systems. The system features special collimators to focus on the heart, collecting up to four times more counts than conventional, parallel-hole collimators. A 3-D reconstruction algorithm models the position of each of the 48,000 collimator holes on each detector. This enables sophisticated distant-dependent isotropic (3-D) resolution recovery. It can complete a full SPECT scan in as little as four minutes. 

GE Healthcare received U.S. clearance for the Brivo NM615 in January. The advanced single-head gamma camera enables lower amounts (up to 50 percent) of radiotracers and the potential for shorter exam times. This is made possible with a new detector design. The system is designed to handle larger patients with a 70 cm bore and table capable of handling patients up to 500 pounds. The system can be upgraded easily onsite to the Discovery NM630 or the Discovery NM/CT 670 SPECT/CT hybrid systems.  

Comparison Chart

This story was an introduction to the SPECT and SPECT/CT comparison cahrt that appeared in the May-June 2012 issue of DAIC. To access the chart, click on the "Comparison Chart" tab at the top of the website page. Participants in the chart include:

 

Digirad - www.digirad.com

GE Healthcare - www.gehealthcare.com

Philips Healthcare - www.healthcare.philips.com

Siemens Medical Solutions - www.medical.siemens.com

 

References:
1. Tali Sharir, Piotr J. Slomka, Sean W. Hayes, et al. “Multicenter Trial of High-Speed Versus Conventional Single-Photon Emission Computed Tomography Imaging: Quantitative Results of Myocardial Perfusion and Left Ventricular Function.” JACC, May 4, 2010, Vol. 55, No. 18.
2. E. Gordon DePuey MD, Srinivas Bommireddipalli MD, John Clark CNMT, “A comparison of the image quality of full-time myocardial perfusion SPECT vs wide beam reconstruction half-time and half-dose SPECT.” Journal of Nuclear Cardiolog, April 2011, Vol. 18, No. 2. 

Related Content

ASNC, SNMMI, position statement, myocardial perfusion PET, coronary artery disease
News | PET Imaging| September 01, 2016
September 1, 2016 — The American Society for Nuclear Cardiology (ASNC) and the Society of...
UltraSPECT, Xpress3.Cardiac, nuclear imaging, RWJPE, New Jersey, Robert Wood Johnson Physician Enterprise
News | SPECT Imaging| July 25, 2016
UltraSPECT Inc. announced recently that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-...
ASNC, SNMMI, PET standard, Pet cardiac imaging, PET nuclear imaging, perfusion imaging

An example of a cardiac PET-CT imaging, should a color coded image of the left ventricle to help assess myocardial perfusion to detect ischemia using a Siemens scanner.

News | Nuclear Imaging| July 19, 2016
 
Cell>Point, license agreement, China, United Eastern Pharmaceutical, Oncardia imaging agent
News | Radiopharmaceuticals and Tracers| July 07, 2016
July 7, 2016 — Cell>Point announced in mid-June it has entered into an...
SNMMI, appropriate use criteria, AUC, PAMA, qualified provider-led entity, PLE
News | Clinical Decision Support| June 27, 2016
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has been named a qualified provider-led entity (PLE)...
Philips, SNMMI 2016, Vereos digital PET/CT, time-of-flight, IntelliSpace 8.0, nuclear imaging
News | Nuclear Imaging| June 14, 2016
Philips announced it would be showcasing a variety of nuclear imaging solutions at the Society of Nuclear Medicine and...
Siemens Healthineers, SNMMI '16, molecular imaging, syngo.via, Biograph Horizon PET/CT, mobile configuration
Technology | Nuclear Imaging| June 09, 2016
At the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Siemens Healthineers will...
nuclear medicine, global market, radiopharmaceuticals, MEDraysintell, SNMMI 2016
News | Nuclear Imaging| June 08, 2016
MEDraysintell estimates that the global market for nuclear medicine (radiopharmaceuticals) reached $4.3 billion in 2015...
cardiac PET, myocardial perfusion, PET-CT, cardiac perfusion

A PET-CT cardiac perfusion exam from a Siemens Biograph scanner. The black and white areas of the image show the CT imaging of the anatomy. The colored portion shows the PET overlay on the myocardium and is color-coded to show tracer uptake values. This can show areas of the heart muscle where there are perfusion defects cause by infarcts or coronary artery blockages due to a heart attack and help determine the severity of the ischemia.

Feature | PET Imaging| June 03, 2016 | Dave Fornell
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enabl
Medic Vision, SafeCT-29, NEMA XR-29, Smart Dose, computed tomography
Technology | Computed Tomography (CT)| May 31, 2016
Medic Vision Imaging Solutions Ltd. announced the U.S. Food and Drug Administration (FDA) clearance of SafeCT-29 to...
Overlay Init